This is the Magellan website for behavioral health providers
Magellan Health

Medication-Assisted Treatment (MAT) 

Our national MAT initiative seeks to increase the use of acamprosate, naltrexone (both in oral and injectable form), buprenorphine and new medications as their proven benefits emerge — in combination with proven psychosocial interventions — in the treatment of substance use disorders where clinically appropriate. 

How does Magellan’s program work?

  • Focuses on patients who have been discharged from inpatient substance use treatment programs
  • Targets individuals receiving outpatient case or disease management services
  • Monitors the number of cases in which physicians are prescribing medications and follows member readmission rates
  • Involves continual collaboration with Magellan’s health plan partners to help facilitate the incorporation of these medications into client formularies
  • Advocates provider education on the importance of using appropriate medications when developing members’ substance use disorder treatment plans. 

Continuing education

Presented by Gary Henschen, MD, LFAPA, Magellan’s senior vice president, medical director of medical management, Magellan offers the following courses for CE credits:

  • Medication-Assisted Treatment for Opiate Use Disorders (generic)
  • Medication-Assisted Treatment for Opiate Use Disorders in Youth and Young Adults

These trainings are available after secure sign-in on the Magellan provider website. Magellan providers are eligible to receive 1.0 Continuing Education Clock Hour for completing each webinar.

  1. Sign in to this website.
  2. Select Online Training from the Education top menu.
  3. Find the training and supporting materials under Courses Offered for CE Credit.

  Trainingicon